Systemic Lupus Erythematosus - Clinical Aspects: Translational Studies

Session Type: ACR Abstract Submissions
Wednesday, November 9, 2011: 9:00 AM-10:30 AM
W470b (McCormick Place West)
Moderators: Jennifer H. Anolik, MD, PhD, University of Rochester and Anisur Rahman, FRCP, PhD, University College London
9:00 AM
Members of the Receptor for Advanced Glycation Endproducts Axis Associate with Systemic Lupus Erythematosus, and May Serve As a Brake to Disease Activity
Manish Jain, Michael Amato, Robert M. Clancy, Peter M. Izmirly and Jill P. Buyon, New York University School of Medicine, New York, NY
9:15 AM
Regulatory Role of Umbilical Cord Mesenchymal Stem Cells on Treg and Th17 Cells in Patients with Systemic Lupus Erythematosus
Dandan Wang, Huiqing Liu, Xia Li and Lingyun Sun, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
9:30 AM
N-Acetylcysteine Improves Disease Activity by Blocking the Mammalian Target of Rapamycin in T Cells of Lupus Patients
Zhiwei Lai1, Robert Hanczko1, Eduardo Bonilla1, Adam Bartos1, Tiffany Telarico2, Gabriella Miklossy3, Brandon Clair2, John Jimah3, Edward Doherty4, Lisa Francis1, Hajra I. Tily5, Ricardo Garcia1, Maha M. Dawood4, Jianghong Yu1, Irene Ramos1, Travis Boevin1, Stephen Faraone1, Paul E. Phillips6 and Andras Perl3, 1SUNY, Syracuse, NY, 2SUNY Upstate Medical University, Syracuse, NY, 3Upstate Medical University, Syracuse, NY, 4SUNY Upstate, Syracuse, NY, 5SUNY, NY, 6SUNY-Upstate Medical Univ, Syracuse, NY
9:45 AM
10:00 AM
Interferon-Alpha Activity Levels Increase Immediately Preceding Clinical Classification of Systemic Lupus
Julie M. Robertson1, Latisha Heinlen2, Jourdan Anderson1, Timothy B. Niewold3, Michael P. Keith4, John B. Harley5 and Judith A. James6, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2OUHSC, Oklahoma City, OK, 3University of Chicago, Chicago, IL, 4National Naval Medical Center, Bethesda, MD, 5Cincinnati Children's Hospital Medical Center and the US Department of Veterans Affairs Medical Center, Cincinnati, OH, 6Oklahoma Medical Research Foundation and Oklahoma University Health Sciences Center, Oklahoma City, OK
10:15 AM
Vascular Biomarkers and Risk of Treatment Failure in the Maintenance Phase of a Randomized Multicenter Trial Comparing Mycophenalate Mofetil and Azathioprine for Lupus Nephritis
Robert M. Clancy1, Peter M. Izmirly1, E.M. Ginzler2 and On Behalf of the Investigators in the MMF/AZA Lupus Nephritis Main Trial1, 1New York University School of Medicine, New York, NY, 2SUNY-Downstate Medical Center, Brooklyn, NY
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.